Implications of recent hypertension trials for the generalist physician: whom do we treat, and how?
The publication of the results of the Swedish Trial in Old Patients with Hypertension-2 (STOP-2) and the termination of the doxazocin arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack (ALLHAT) study again raise the question of whether all antihypertensives deliver equa...
Na minha lista:
| Publicado no: | Curr Control Trials Cardiovasc Med |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2000
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59591/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11714401/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-1-1-022 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|